The characteristics of iPSC are similar to those of embryonic stem cells (ESC)-infinite expansion + tridermal cell differentiation potential.

Technical Guidelines for the Application of Decentralized Clinical Trials in Clinical Research and Development of Drugs for Rare Diseases

On July 22, 2024, it was reported that two months after receiving stem cell treatment, patients with multiple sclerosis (MS) had improved their disability and showed a short-term reduction in brain lesion volume.

In recent years, with the continuous development of regenerative medicine in my country, a number of new stem cell drugs IND have been approved, bringing new hope to patients suffering from chronic diseases!

As a new anti-Parkinson's disease drug, safenamide provides new treatment options for patients with Parkinson's disease through its unique dual mechanism of action.

iPSC technology has both the totality of cell differentiation and its own infinite replication ability, providing cure possibilities for many untreatable diseases.

Stem cell-based therapies have become a promising treatment that leverages the regenerative potential of stem cells to repair damaged neural tissue and neural circuits for the treatment of various nervous system diseases.

As the origin cells of the human body, stem cells have unique effects that have not been seen in traditional medicines in improving sub-health status, preventing and treating chronic diseases, and beautifying and resisting aging.